Status:
COMPLETED
A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis
Lead Sponsor:
AstraZeneca
Conditions:
Erosive Esophagitis
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This study looks at the healing rates in patients with Erosive Esophagitis (EE) when treated with either esomeprazole or lansoprazole
Eligibility Criteria
Inclusion
- Episodes of heartburn (described as a burning feeling, rising from the stomach or lower part of the chest up towards the neck) for 2 days or more during the last 7 days prior to baseline.
- Confirmed Erosive Esophagitis within 1 week prior to starting the study.
Exclusion
- Any signs of gastrointestinal bleeding at the time of the starting the study.
- Any previous gastric or esophageal surgery.
- Various gastrointestinal diseases as listed in the protocol.
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2003
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00641602
Start Date
December 1 2002
End Date
August 1 2003
Last Update
March 26 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.